These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 15817342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
    Zuur CL, Simis YJ, Lamers EA, Hart AA, Dreschler WA, Balm AJ, Rasch CR.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):490-6. PubMed ID: 19135315
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ.
    J Clin Oncol; 2007 Aug 20; 25(24):3759-65. PubMed ID: 17704425
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
    Lamers-Kuijper E, Schwarz M, Rasch C, Mijnheer B.
    Med Dosim; 2007 Aug 20; 32(4):237-45. PubMed ID: 17980823
    [Abstract] [Full Text] [Related]

  • 8. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Kirwan J, Mendenhall WM.
    Laryngoscope; 2009 Oct 20; 119(10):1966-74. PubMed ID: 19688858
    [Abstract] [Full Text] [Related]

  • 9. Effect of radiotherapy on retro-cochlear auditory pathways.
    Low WK, Burgess R, Fong KW, Wang DY.
    Laryngoscope; 2005 Oct 20; 115(10):1823-6. PubMed ID: 16222203
    [Abstract] [Full Text] [Related]

  • 10. Ototoxicity after radiotherapy for head and neck tumors.
    Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):469-79. PubMed ID: 17236969
    [Abstract] [Full Text] [Related]

  • 11. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 12. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648
    [Abstract] [Full Text] [Related]

  • 13. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M, Fucilli FI, Castagna R, Bambace S, Pili G, Tramacere F, Russo D, Francavilla MC.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1036-43. PubMed ID: 16750321
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Damage to inner ear function caused by the effect of ionizing rays].
    Strohm M, Ahlemann LM, Böhringer WK.
    HNO; 1985 Jan 15; 33(1):26-9. PubMed ID: 3972645
    [Abstract] [Full Text] [Related]

  • 17. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
    Ortholan C, Chamorey E, Benezery K, Thariat J, Dassonville O, Poissonnet G, Bozec A, Follana P, Peyrade F, Sudaka A, Gerard JP, Bensadoun RJ.
    Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):178-86. PubMed ID: 18565687
    [Abstract] [Full Text] [Related]

  • 18. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1320-5. PubMed ID: 17418969
    [Abstract] [Full Text] [Related]

  • 19. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
    Kim TH, Cho KH, Pyo HR, Lee JS, Han JY, Zo JI, Lee JM, Hong EK, Choi IJ, Park SY, Shin KH, Kim DY, Kim JY.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):995-1002. PubMed ID: 15990000
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.